abstract |
Selective neurotransmitter binding compounds that are useful for the treatment of various neurological and psychological disorders, e.g., ADHD are disclosed. Such compounds are 4-phenyl substituted tetrahydroisoquinolines having the Formula IA, IB, IIA, IIB, IIIA or IIIC as set forth in the specification. |